These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1513627)

  • 1. [Histiocytic proliferative diseases in children].
    Makhonova LA; Peterson IS; Zemskova VI; Koposov PV; Tupitsyn NN
    Pediatriia; 1992; (2):20-4. PubMed ID: 1513627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature.
    Cohen-Barak E; Rozenman D; Schafer J; Krausz J; Dodiuk-Gad R; Gabriel H; Shani-Adir A
    Int J Dermatol; 2014 May; 53(5):558-63. PubMed ID: 23968608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a MOPP-type regimen in histiocytosis X--a Southwest Oncology Group study.
    Komp DM; Silva-Sosa M; Miale T; Sexauer C; Herson J
    Cancer Treat Rep; 1977 Aug; 61(5):855-9. PubMed ID: 329979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histiocytoses: clinical presentation and differential diagnosis.
    Gonzalez CL; Jaffe ES
    Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosai Dorfman disease and peripheral T-cell lymphoma: A rare co-occurrence.
    Tiwari V; Pareek A; Ghori H; Ahirwar M
    J Postgrad Med; 2019; 65(1):62-63. PubMed ID: 30464074
    [No Abstract]   [Full Text] [Related]  

  • 6. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 7. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.
    Goyal G; Young JR; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Davidge-Pitts CJ; Hurtado MD; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Go RS;
    Mayo Clin Proc; 2019 Oct; 94(10):2054-2071. PubMed ID: 31472931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic difficulties and positive therapeutic response in a patient with sinus histiocytosis with massive lymphadenopathy.
    Picco P; Buoncompagni A; Pistoia V; Di Rocco M; Giustardi A; Brisigotti M; Comelli A; Iannone A; Borrone C
    Eur J Pediatr; 1993 Aug; 152(8):699. PubMed ID: 8404978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy in the treatment program for histiocytosis X in children].
    Zemskova VI
    Pediatriia; 1983 Apr; (4):28-31. PubMed ID: 6603603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histiocytosis-related proliferative disorders in children].
    Makhonova LA; Pichugina LIu; Peterson IS; Tupitsyn NN; Kiselev AV
    Vopr Onkol; 2000; 46(4):452-5. PubMed ID: 11147424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
    Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
    [No Abstract]   [Full Text] [Related]  

  • 12. Histiocytosis X.
    Talbot ML
    Am Surg; 1974 Feb; 40(2):89-96. PubMed ID: 4810636
    [No Abstract]   [Full Text] [Related]  

  • 13. Survivorship Issues in Adult Patients With Histiocytic Neoplasms.
    O'Brien K; Dave R; Shekhar S; Hannah-Shmouni F; Comis LE; Solomon BI; Chen M; Gahl WA; FitzGibbon E; Gochuico BR; Estrada-Veras JI
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1312-1318. PubMed ID: 34781266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy].
    Martínez-Fernández E; Gil-Néciga E; López-Domínguez JM; Casado-Chocán JL; Garzón F; Franco E; Abrio MV
    Rev Neurol; 1999 Dec 16-31; 29(12):1349-50. PubMed ID: 10652772
    [No Abstract]   [Full Text] [Related]  

  • 15. Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
    Shamsian BS; Goudarzipour K; Alavi S; Jadali F; Gharib A; Aghakhani R; Arzanian MT; Rezaei N
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e245-6. PubMed ID: 20628318
    [No Abstract]   [Full Text] [Related]  

  • 16. Orbital Rosai-Dorfman disease: a literature review.
    McClellan SF; Ainbinder DJ
    Orbit; 2013 Oct; 32(5):341-6. PubMed ID: 23895540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis: clinical experience with 124 patients.
    Rivera-Luna R; Martinez-Guerra G; Altamirano-Alvarez E; Martinez-Avalos A; Cardenas-Cardoz R; Ayon-Cardenas A; Ruiz-Maldonado R; Lopez-Corella E
    Pediatr Dermatol; 1988 Aug; 5(3):145-50. PubMed ID: 3264610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
    J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A contribution to treatment of histiocytosis X in children (author's transl)].
    Najbrt V
    Cesk Dermatol; 1978 Jan; 53(1):24-7. PubMed ID: 306895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.